Last reviewed · How we verify

NCT06146361

Vale+Tú Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19

Completed NA Results posted Last updated 23 April 2025
What this trial tests

NA trial testing COVID-19 Group Problem Solving in COVID-19 in 359 participants. Completed in 14 February 2024.

Timeline
3 November 2023
Primary endpoint
14 February 2024
14 February 2024

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment359
Start date3 November 2023
Primary completion14 February 2024
Estimated completion14 February 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

18 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants Compliant With COVID Vaccination Guidelines as Assessed by a Survey Primary · Baseline

Measure of compliance with COVID vaccination guidelines.

GroupValue95% CI
COVID-19 Group Problem Solving30
Group Problem Solving Plus Booster Session28
Standard of Care33
Number of Participants Compliant With COVID Vaccination Guidelines as Assessed by a Survey Primary · 4 weeks post intervention

Post test measure of compliance with COVID vaccination guidelines.

GroupValue95% CI
COVID-19 Group Problem Solving59
Group Problem Solving Plus Booster Session53
Standard of Care53
Mask Wearing Frequency as Assessed by a Survey Primary · Baseline

Mask Wearing frequency is reported as a score, ranging from 1-4, with a higher score indicating greater mask wearing frequency.

GroupValue95% CI
COVID-19 Group Problem Solving2.050± 0.915
Group Problem Solving Plus Booster Session2.109± 0.836
Standard of Care1.927± 0.842
Mask Wearing Frequency as Assessed by a Survey Primary · 4 weeks post intervention

Mask Wearing frequency is reported as a score, ranging from 1-4, with a higher score indicating greater mask wearing frequency.

GroupValue95% CI
COVID-19 Group Problem Solving1.720± 0.621
Group Problem Solving Plus Booster Session1.798± 0.567
Standard of Care1.632± 0.673
Percentage of Participants Who Contacted an Agency About the Gold Card Primary · 4 weeks post intervention

Percentage of participants who reported contacting a local community or health agency to request the Gold Card a local medical insurance for low income individuals living in Harris County.

GroupValue95% CI
COVID-19 Group Problem Solving6
Group Problem Solving Plus Booster Session10
Standard of Care4
Percentage of Participants Who Reported Contacting the Agency for Assistance to Get Food Primary · 4 weeks post intervention

Percentage of participants who reported seeking food assistance from a local community organization.

GroupValue95% CI
COVID-19 Group Problem Solving10
Group Problem Solving Plus Booster Session13
Standard of Care3
Percentage of Participants Who Reported Contacting the Agency for Assistance With Health Care Resources Primary · 4 weeks post intervention

Percentage of participants who reported seeking medical assistance or health advice from a local clinic or community organization.

GroupValue95% CI
COVID-19 Group Problem Solving2
Group Problem Solving Plus Booster Session2
Standard of Care0

Sponsor's own description

The purpose of this study is to assess the extent to which LDL report increased adherence with COVID 19 mitigation practices 1 month post intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of COVID-19 Group Problem Solving

Trials testing the same drug.

Other recruiting trials for COVID-19

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06146361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing